BioCentury
ARTICLE | Clinical News

GVAX: Phase II started

July 5, 2004 7:00 AM UTC

The Southwest Oncology Group began a U.S. Phase II trial in about 100 patients with advanced-stage BAC, a subtype of non-small cell lung cancer (NSCLC). CEGE said results of a Phase I/II trial showed ...